Immunogenicity and Safety of the Inactivated, Split-Virion Influenza Vaccine, Northern Hemisphere 2007-2008 Formulation (Intramuscular Route).
Phase of Trial: Phase II
Latest Information Update: 10 Apr 2014
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Sanofi
- 07 Apr 2009 Actual initiation date changed from Sep 2007 to Aug 2007 as reported by ClinicalTrials.gov.
- 07 Apr 2009 Actual end date (Dec 2007) added as reported by ClinicalTrials.gov.
- 07 Apr 2009 Actual patient number (124) added as reported by ClinicalTrials.gov.